TABLE 3.
Proband (N = 181) |
All Spouses (N = 267)* |
Normolipidemic† Spouses (N3192) | ||||
---|---|---|---|---|---|---|
Locus | Genotype | Frequencies (n) | TG, mg/dL‡ | Frequencies (n) | TG, mg/dL‡ | Frequencies (n) |
APOA5c0.56C≥G | 1,1 | 0.785 (142) | 3823149§ | 0.8653 (231) | 129359 | 0.870 (167) |
1,2 | 0.188 (34) | 4973335 | 0.127 (34) | 128365 | 0.125 (24) | |
2,2 | 0.028 (5) | 9283572 | 0.007 (2) | 122 | 0.005 (1) | |
APOC3c0.386C≥G | 1,1 | 0.724 (131) | 4263266 | 0.8163 (218) | 122354¶ | 0.859 (165) |
1,2 | 0.265 (48) | 3983122 | 0.169 (45) | 156375 | 0.135 (26) | |
2,2 | 0.011 (2) | 3413134 | 0.015 (4) | 182339 | 0.005 (1) |
Includes all individuals, no exclusion criteria applied.
Cholesterol and triglyceride levels<age-sex-specific 75th percentile values.
Mean triglyceride levels±SD.
P<0.004 (ANOVA) for the effect of the APO5c0.56C>G genotype on log triglyceride levels.
P<0.01 for comparison between allele frequencies in probands versus all family spouses.
P<0.007 (ANOVA) for the effect of the APOC3c0.386C>G genotype on log triglyceride levels.